“…Despite the existence of several reviews and meta-analyses on VR for stroke ( Lohse et al, 2014 ; Gibbons et al, 2016 ; Laver et al, 2017 ), Parkinson disease ( Dockx et al, 2016 ), multiple sclerosis ( Massetti et al, 2016 ) and multiple neurological conditions ( Cano Porras et al, 2018 ), results about the effectiveness of VR-mediated training are yet inconclusive. One main reason for this is that many studies include small sample sizes as compared to the great variability of the tested clinical populations, which makes extremely difficult to control for other variables such lesion location and size, severity of impairments, phase of recovery and, importantly for cognitive functions, no separation between age or level of education ( Fetta et al, 2017 ). Another key factor is the choice (or lack) of the control group to compare the effect with: for instance, for home rehabilitation, if the effectiveness of a VR-mediated training (with the therapist remotely shaping and monitoring the training program) is compared to that of 1-to-1 therapy sessions of the same intensity and duration with a highly trained clinician, the non-inferiority of the VR-mediated training should be actually considered as a positive outcome, independently of other socio-economic advantages such as reduced costs.…”